Product Code: ETC018359 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Saudi Arabia is one of the largest pharmaceutical and chemical markets in the Middle East. Considered to be a major market for both raw materials and finished products, it provides opportunities for companies across the globe to expand their presence in this region. The country`s healthcare sector has seen significant growth over recent years due to increased government investment, with demand expected to increase further as its population size continues to grow. Saudi Arabia pharmaceutical industry faces challenges such as high prices, lack of specialized workforce and limited access to innovative medicines but also offers great potential for growth due to its strong economic base.
The main drivers of the Saudi Arabia pharmaceutical chemical market are increasing government spending on healthcare services, rising disposable incomes among citizens resulting from higher employment rates and rapid urbanization leading to an increase in chronic diseases that require medical attention. Additionally, public-private partnerships have been developed between domestic firms and international drug manufacturers which has encouraged foreign direct investments (FDI) into R&D activities within Saudi Arabia. In addition there is growing demand for generic drugs due to their lower cost when compared with branded ones thus making them more accessible by many people including those from low income brackets who would otherwise not be able afford expensive treatments or medications without these generics available at much lower costs than any other alternatives.
However, some challenges that remain include lack of technological advances within Saudi`s drug discovery/manufacturing capability; inadequate regulatory approval procedures for new drugs; limited capital investments in research & development activities by public and private organizations due to shortage of funds; and significant dependence on imports from other countries (mainly India).
The Covid-19 pandemic has had an adverse effect on the overall economic outlook across various industries including Pharmaceuticals & Chemicals. Due to lockdown restrictions imposed by governments throughout Middle East region there was disruption witnessed in supply chains resulting into operational difficulties for key players operating within this space. However, it also created huge opportunity across several verticals including production/distribution of disinfectants/sanitizers, personal protective equipment (PPE) etc., consequently leading to increased demand precipitated from these categories thereby mitigating slowdown caused due to Covid-19 crisis situation.
Major Players: Merck KGaA,, Johnson & Johnson , Pfizer Inc., Sanofi SA , GlaxoSmithKline Plc , Novartis AG , Bayer AG , Eli Lilly and Company.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Saudi Arabia pharmaceuticals chemical Market Overview |
3.1 Saudi Arabia Country Macro Economic Indicators |
3.2 Saudi Arabia pharmaceuticals chemical Market Revenues & Volume, 2021 & 2031F |
3.3 Saudi Arabia pharmaceuticals chemical Market - Industry Life Cycle |
3.4 Saudi Arabia pharmaceuticals chemical Market - Porter's Five Forces |
3.5 Saudi Arabia pharmaceuticals chemical Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Saudi Arabia pharmaceuticals chemical Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Saudi Arabia pharmaceuticals chemical Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
4 Saudi Arabia pharmaceuticals chemical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growth in the healthcare sector and increasing government investments in pharmaceuticals. |
4.2.2 Rising population and increasing prevalence of chronic diseases. |
4.2.3 Technological advancements leading to the development of innovative pharmaceutical chemicals. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and compliance standards. |
4.3.2 Pricing pressures and competition within the pharmaceuticals chemical market. |
4.3.3 Economic fluctuations and currency exchange rates impacting imports and exports. |
5 Saudi Arabia pharmaceuticals chemical Market Trends |
6 Saudi Arabia pharmaceuticals chemical Market, By Types |
6.1 Saudi Arabia pharmaceuticals chemical Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Saudi Arabia pharmaceuticals chemical Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Saudi Arabia pharmaceuticals chemical Market Revenues & Volume, By Basic building blocks , 2021-2031F |
6.1.4 Saudi Arabia pharmaceuticals chemical Market Revenues & Volume, By Advanced intermediates , 2021-2031F |
6.1.5 Saudi Arabia pharmaceuticals chemical Market Revenues & Volume, By Active ingredients, 2021-2031F |
6.2 Saudi Arabia pharmaceuticals chemical Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Saudi Arabia pharmaceuticals chemical Market Revenues & Volume, By Cardiovascular , 2021-2031F |
6.2.3 Saudi Arabia pharmaceuticals chemical Market Revenues & Volume, By Neurology , 2021-2031F |
6.2.4 Saudi Arabia pharmaceuticals chemical Market Revenues & Volume, By Oncology , 2021-2031F |
6.2.5 Saudi Arabia pharmaceuticals chemical Market Revenues & Volume, By Infectious diseases, 2021-2031F |
6.2.6 Saudi Arabia pharmaceuticals chemical Market Revenues & Volume, By Metabolic system , 2021-2031F |
6.2.7 Saudi Arabia pharmaceuticals chemical Market Revenues & Volume, By Diabetes , 2021-2031F |
6.2.8 Saudi Arabia pharmaceuticals chemical Market Revenues & Volume, By Other, 2021-2031F |
6.2.9 Saudi Arabia pharmaceuticals chemical Market Revenues & Volume, By Other, 2021-2031F |
6.3 Saudi Arabia pharmaceuticals chemical Market, By Sales Channel |
6.3.1 Overview and Analysis |
6.3.2 Saudi Arabia pharmaceuticals chemical Market Revenues & Volume, By Offline, 2021-2031F |
6.3.3 Saudi Arabia pharmaceuticals chemical Market Revenues & Volume, By Online, 2021-2031F |
7 Saudi Arabia pharmaceuticals chemical Market Import-Export Trade Statistics |
7.1 Saudi Arabia pharmaceuticals chemical Market Export to Major Countries |
7.2 Saudi Arabia pharmaceuticals chemical Market Imports from Major Countries |
8 Saudi Arabia pharmaceuticals chemical Market Key Performance Indicators |
8.1 Research and development (RD) investment in pharmaceutical chemicals. |
8.2 Number of new product launches and patents filed. |
8.3 Adoption rate of advanced manufacturing technologies in pharmaceutical chemical production. |
9 Saudi Arabia pharmaceuticals chemical Market - Opportunity Assessment |
9.1 Saudi Arabia pharmaceuticals chemical Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Saudi Arabia pharmaceuticals chemical Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Saudi Arabia pharmaceuticals chemical Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
10 Saudi Arabia pharmaceuticals chemical Market - Competitive Landscape |
10.1 Saudi Arabia pharmaceuticals chemical Market Revenue Share, By Companies, 2024 |
10.2 Saudi Arabia pharmaceuticals chemical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |